Sysmex America will showcase the XR-Series hematology platform and CentralOps informatics solution at ADLM 2026, highlighting advancements for high-volume clinical labs in hematology, hemostasis, and data integration.
The FDA has cleared Roche’s cobas BV/CV assay, a molecular test that detects bacterial vaginosis and Candida vaginitis from a single swab, enabling streamlined diagnosis on the cobas platform, according to Roche.
Ibex Medical Analytics has received IVDR certification for its breast cancer diagnostic tools, completing regulatory approval for ER, PR, and Ki67 tests, according to a company press release.
The automated assay identifies latent infections in routine laboratory settings with results available in less than 24 hours.
New analysis suggests that higher-sensitivity testing could lower annual spending by more than $3 billion by reducing misdiagnosis.
